Concepedia

Masoud Khorsand

MK

Statistics

Publications

7

Citations

303

H-Index

7

Active since

1996

Affiliations

University of Wisconsin–Madison(Current)

Masoud Khorsand is an author at University of Wisconsin–Madison specializing in medicine, inflammation, and autoimmunity.

Top concepts

Publications per year

1996–2001

7

Publications

7

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.

Mark R. Albertini, Jacquelyn A. Hank, Joan H. Schiller et al. · PubMed · 1997 · 70 citations

, , +17

Multiple cerebral lesions complicating therapy with interleukin-2

Barbara Karp, Jin Yang, Masoud Khorsand et al. · Neurology · 1996 · 52 citations

Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder

Masoud Khorsand, J Lange, Lynn G. Feun et al. · Investigational New Drugs · 1997 · 47 citations

, , +8

Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2

Michael E. Eastman, Masoud Khorsand, Dennis G. Maki et al. · Cancer · 2001 · 43 citations

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.

Joan H. Schiller, Jacquelyn A. Hank, Masoud Khorsand et al. · PubMed · 1996 · 37 citations

, , +20

1–5 of 7